SWL literature
Slider

Patel P. et al., 2019: Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?

Patel P, Fode M, Lue T, Ramasamy R.
Department of Urology, University of Miami, Miami, FL, USA.
Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark.
Department of Urology, University of California, San Francisco, San Francisco, CA, USA.

Abstract 

Some trials have shown an overall benefit of low-intensity extracorporeal shockwave therapy (LI-ESWT) for erectile dysfunction, while others have been unable to find differences between LI-ESWT and sham treatment. In the absence of definitive evidence, patients should only be offered LI-ESWT in an investigational setting or on an off-label basis with a thorough understanding of the risks and benefits.
Eur Urol Focus. 2019 Feb 15. pii: S2405-4569(19)30024-0. doi: 10.1016/j.euf.2019.02.004. [Epub ahead of print]

0
 

Commentaires 1

Peter Alken le vendredi 21 juin 2019 08:21

The first quarter of 2019 offers at least 7 publication on LI-ESWT (1-7)
The LI-ESWT community seems to stand up like one man to defend this therapy, which tries to restore the aging tissue of the aging male, against criticism and skepticism.

1 Faix A, Chevallier D.
Low-intensity extracorporeal shockwave therapy for erectile dysfunctio: a new option ?
Rev Med Suisse. 2019 Mar 13;15(642):590-595.

2 Liu T, Shindel AW, Lin G, Lue TF.
Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy.
Int J Impot Res. 2019 Jan 22. doi: 10.1038/s41443-019-0113-3.

3 Patel P, Fode M, Lue T, Ramasamy R.
Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?
Eur Urol Focus. 2019 Feb 15. pii: S2405-4569(19)30024-0. doi: 10.1016/j.euf.2019.02.004.

4 Patel P, Huang C, Molina M, Ramasamy R.
Clinical trial update on shockwave therapy and future of erectile function restoration.
Int J Impot Res. 2019 Jan 22. doi: 10.1038/s41443-019-0115-1.

5 Sokolakis I, Dimitriadis F, Teo P, Hatzichristodoulou G, Hatzichristou D, Giuliano F.
The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies.
J Sex Med. 2019 Feb;16(2):168-194. doi: 10.1016/j.jsxm.2018.12.016.

6 Sokolakis I, Hatzichristodoulou G.
Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials.
Int J Impot Res. 2019 Jan 21. doi: 10.1038/s41443-019-0117-z.

7 Usta MF, Gabrielson AT, Bivalacqua TJ.
Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: a critical review. Int J Impot Res. 2019 Feb 1. doi: 10.1038/s41443-019-0121-3.

The first quarter of 2019 offers at least 7 publication on LI-ESWT (1-7) The LI-ESWT community seems to stand up like one man to defend this therapy, which tries to restore the aging tissue of the aging male, against criticism and skepticism. 1 Faix A, Chevallier D. Low-intensity extracorporeal shockwave therapy for erectile dysfunctio: a new option ? Rev Med Suisse. 2019 Mar 13;15(642):590-595. 2 Liu T, Shindel AW, Lin G, Lue TF. Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy. Int J Impot Res. 2019 Jan 22. doi: 10.1038/s41443-019-0113-3. 3 Patel P, Fode M, Lue T, Ramasamy R. Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition? Eur Urol Focus. 2019 Feb 15. pii: S2405-4569(19)30024-0. doi: 10.1016/j.euf.2019.02.004. 4 Patel P, Huang C, Molina M, Ramasamy R. Clinical trial update on shockwave therapy and future of erectile function restoration. Int J Impot Res. 2019 Jan 22. doi: 10.1038/s41443-019-0115-1. 5 Sokolakis I, Dimitriadis F, Teo P, Hatzichristodoulou G, Hatzichristou D, Giuliano F. The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies. J Sex Med. 2019 Feb;16(2):168-194. doi: 10.1016/j.jsxm.2018.12.016. 6 Sokolakis I, Hatzichristodoulou G. Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials. Int J Impot Res. 2019 Jan 21. doi: 10.1038/s41443-019-0117-z. 7 Usta MF, Gabrielson AT, Bivalacqua TJ. Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: a critical review. Int J Impot Res. 2019 Feb 1. doi: 10.1038/s41443-019-0121-3.
Invité
dimanche 22 septembre 2019
STORZ MEDICAL AG
Lohstampfestrasse 8
8274 Tägerwilen
Switzerland
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05

www.storzmedical.com